Angiogenesis is present in experimental autoimmune encephalomyelitis and pro-angiogenic factors are increased in multiple sclerosis lesions

Journal of Neuroinflammation

Volumn 7, Issue , 2010, Pages

  Seabrook, Timothy J ^a   Littlewood Evans, Amanda ^a   Brinkmann, Volker ^a   Pöllinger, Bernadette ^a   Schnell, Christian ^a   Hiestand, Peter C ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN 1; ANGIOPOIETIN RECEPTOR; CD31 ANTIGEN; METEORIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN A;

ACUTE DISEASE; ADULT; AGED; ALLERGIC ENCEPHALOMYELITIS; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL DIAMETER; BRAIN TISSUE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAY MATTER; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUMBAR SPINAL CORD; MALE; MULTIPLE SCLEROSIS; NONHUMAN; PROTEIN EXPRESSION; RAT; RELAPSE; VASODILATATION; WHITE MATTER; ANIMAL; GUINEA PIG; LEWIS RAT; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY;

ADULT; AGED; ANGIOGENESIS INDUCING AGENTS; ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GUINEA PIGS; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEOVASCULARIZATION, PATHOLOGIC; RATS; RATS, INBRED LEW; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 78650348569     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-7-95     Document Type: Article

References (44)

1. Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol 2005, 23:683-747. 10.1146/annurev.immunol.23.021704.115707, 15771584.
2. Frohman EM, Stuve O, Havrdova E, Corboy J, Achiron A, Zivadinov R, et al. Therapeutic considerations for disease progression in multiple sclerosis - Evidence, experience, and future expectations. Arch Neurol 2005, 62:1519-1530. 10.1001/archneur.62.10.1519, 16216934.
3. De Jager PL, Rossin E, Pyne S, Tamayo P, Ottoboni L, Viglietta V, et al. Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8(low) cells. Brain 2008, 131:1701-1711. 10.1093/brain/awn118, 2730047, 18567923.
4. De Jager PL, Simon KC, Munger KL, Rioux JD, Hafler DA, Ascherio A. Integrating risk factors - HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis. Neurol 2008, 70:1113-1118.
5. Frohman EM, Racke MK, Raine CS. Medical progress: Multiple sclerosis - The plaque and its pathogenesis. New Engl J Med 2006, 354:942-955. 10.1056/NEJMra052130, 16510748.
6. Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008, 57:178-201. 10.1016/j.neuron.2008.01.003, 18215617.
7. Hochmeister S, Grundtner R, Bauer J, Engelhardt B, Lyck R, Gordon G, et al. Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis. J Neuropathol Exp Neurol 2006, 65:855-865. 10.1097/01.jnen.0000235119.52311.16, 16957579.
8. Juhler M, Barry DI, Offner H, Konat G, Klinken L, Paulson OB. Blood-Brain and Blood Spinal-Cord Barrier Permeability During the Course of Experimental Allergic Encephalomyelitis in the Rat. Brain Res 1984, 302:347-355. 10.1016/0006-8993(84)90249-X, 6610460.
9. Kerschensteiner M, Stadelmann C, Buddeberg BS, Merkler D, Bareyre FM, Anthony DC, et al. Targeting experimental autoimmune encephalomyelitis lesions to a predetermined axonal tract system allows for refined behavioral testing in an animal model of multiple sclerosis. Am J Pathol 2004, 164:1455-1469. 1615356, 15039233.
10. Genain CP, Cannella B, Hauser SL, Raine CS. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nature Medicine 1999, 5:170-175. 10.1038/5532, 9930864.
11. Filippi M, Bakshi R, Rovaris M, Comi G. MRI and multiple sclerosis: What happened in the last 10 years?. J Neuroimaging 2007, 17:1S-2S. 10.1111/j.1552-6569.2007.00128.x, 17425726.
12. Bakshi R. Magnetic resonance imaging advances in multiple sclerosis. J Neuroimaging 2005, 15:5S-9S. 10.1177/1051228405283362, 16385014.
13. Wuerfel J, Bellmann-Strobl J, Brunecker P, Aktas O, McFarland H, Villringer A, et al. Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study. Brain 2004, 127:111-119. 10.1093/brain/awh007, 14570816.
14. Jain RK, di Tomaso E, Duda DG, Loeffler JS, Sorensen AG, Batchelor TT. Angiogenesis in brain tumours. Nature Reviews Neuroscience 2007, 8:610-622. 10.1038/nrn2175, 17643088.
15. Rigau V, Morin M, Rousset MC, de Bock F, Lebrun A, Coubes P, et al. Angiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy. Brain 2007, 130:1942-1956. 10.1093/brain/awm118, 17533168.
16. Zlokovic BV. Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci 2005, 28:202-208. 10.1016/j.tins.2005.02.001, 15808355.
17. Kirk S, Frank JA, Karlik S. Angiogenesis in multiple sclerosis: is it good, bad or an epiphenomenon?. J Neurol Sci 2004, 217:125-130. 10.1016/j.jns.2003.10.016, 14706213.
18. Kirk SL, Karlik SJ. VEGF and vascular changes in chronic neuroinflammation. J Autoimmun 2003, 21:353-363. 10.1016/S0896-8411(03)00139-2, 14624758.
19. Roscoe WA, Welsh ME, Carter DE, Karlik SJ. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE. J Neuroimmunol 2009, 209:6-15. 10.1016/j.jneuroim.2009.01.009, 19233483.
20. Proescholdt MA, Jacobson S, Tresser N, Oldfield EH, Merrill MJ. Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats. J Neuropathol Exp Neurol 2002, 61:914-925.
21. Croll SD, Ransohoff RM, Cai N, Zhang Q, Martin FJ, Wei T, et al. VEGF-mediated inflammation precedes angiogenesis in adult brain. Exp Neurol 2004, 187:388-402. 10.1016/j.expneurol.2004.02.010, 15144865.
22. Su JJ, Osoegawa M, Matsuoka T, Minohara M, Tanaka M, Ishizu T, et al. Upregulation of vascular growth factors in multiple sclerosis: Correlation with MRI findings. J Neurol Sci 2006, 243:21-30. 10.1016/j.jns.2005.11.006, 16376944.
23. Holley JE, Newcombe J, Whatmore JL, Gutowski NJ. Increased blood vessel density and endothelial cell proliferation in multiple sclerosis cerebral white matter. Neurosci Lett 2010, 470:65-70. 10.1016/j.neulet.2009.12.059, 20036712.
24. Berger C, Hiestand P, Kindler-Baumann D, Rudin M, Rausch M. Analysis of lesion development during inflammation and remission in a rat model of experimental autoimmune encephalomyelitis by visulalization of macrophage infiltration, demyelination and blood brain-barrier damage. NMR Biomed 2006, 19:101-107. 10.1002/nbm.1007, 16411166.
25. Hildebrand T, Ruegsegger P. A new method for the model-independent assessment of thickness in three-dimensional images. Journal of Microscopy-Oxford 1997, 185:67-75.
26. Rausch M, Tofts PS, Lervik P, Walmsley AR, Mir A, Schubart A, et al. Characterization of white matter damage in animal models of multiple sclerosis by magnetization transfer ratio and quantitative mapping of the apparent bound proton fraction f*. Multiple Sclerosis 2009, 15:16-27. 10.1177/1352458508096006, 18971220.
27. Koyanagi I, Tator CH, Piepmeier JM, Lea PJ, Turnbull IM. 3-Dimensional Analysis of the Vascular System in the Rat Spinal-Cord with Scanning Electron-Microscopy of Vascular Corrosion Casts .1. Normal Spinal-Cord. Neurosurgery 1993, 33:277-284. 10.1227/00006123-199308000-00015, 8367051.
28. Williams KC, Zhao WG, Politopoulou G, Male D, Hickey WF. Inhibition of experimental allergic encephalomyelitis with an antibody that recognizes a novel antigen expressed on lymphocytes, endothelial cells, and microglia. Lab Invest 2000, 80:313-326.
29. Tham E, Gielen AW, Khademi M, Martin C, Piehl F. Decreased expression of VEGF-A in rat experimental autoimmune encephalomyelitis and in cerebrospinal fluid mononuclear cells from patients with multiple sclerosis. Scand J Immunol 2007, 65:310.
30. Proescholdt MA, Heiss JD, Walbridge S, Muhlhauser J, Capogrossi MC, Oldfield EH, et al. Vascular endothelial growth factor (VEGF) modulates vascular permeability and inflammation in rat brain. J Neuropathol Exp Neurol 1999, 58:613-627. 10.1097/00005072-199906000-00006, 10374752.
31. Park JA, Lee HS, Ko KJ, Park SY, Kim JH, Choe G, et al. Meteorin regulates angiogenesis at the gliovascular interface. Glia 2008, 56:247-258. 10.1002/glia.20600, 18059000.
32. Jackson JR, Seed MP, Kircher CH, Willoughby DA, Winkler JD. The codependence of angiogenesis and chronic inflammation. FASEB J 1997, 11:457-465.
33. Mor F, Quintana FJ, Cohen IR. Angiogenesis-inflammation cross-talk: Vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization. J Immunol 2004, 172:4618-4623.
34. Noonan DM, Barbaro ADL, Vannini N, Mortara L, Albini A. Inflammation, inflammatory cells and angiogenesis: decisions and indecisions. Cancer Metastasis Rev 2008, 27:31-40. 10.1007/s10555-007-9108-5, 18087678.
35. Jeon SH, Chae BC, Kim HA, Seo GY, Seo DW, Chun GT, et al. Mechanisms underlying TGF-beta 1-induced expression of VEGF and Flk-1 in mouse macrophages and their implications for angiogenesis. J Leukoc Biol 2007, 81:557-566. 10.1189/jlb.0806517, 17053163.
36. Xiong M, Elson G, Legarda D, Leibovich SJ. Production of vascular endothelial growth factor by murine macrophages - Regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway. Am J Pathol 1998, 153:587-598. 1852978, 9708818.
37. Minagar A, Carpenter A, Alexander JS. The destructive alliance: Interactions of leukocytes, cerebral endothelial cells, and the immune cascade in pathogenesis of multiple sclerosis. Neurobiology of Multiple Sclerosis 2007, 79:1-11.
38. Greenberg DA, Jin KL. From angiogenesis to neuropathology. Nature 2005, 438:954-959. 10.1038/nature04481, 16355213.
39. Mueller AM, Pedre X, Stempfl T, Kleiter I, Couillard-Despres S, Aigner L, et al. Novel role for SLPI in MOG-induced EAE revealed by spinal cord expression analysis. J Neuroinflamm 2008, 5:20.
40. Storkebaum E, Lambrechts D, Carmeliet P. VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays 2004, 26:943-954. 10.1002/bies.20092, 15351965.
41. McCloskey DP, Tana MH, Scharfman HE. Modulation of vascular endothelial growth factor (VEGF) expression in motor neurons and its electrophysiological effects. Brain Res Bull 2008, 76:36-44. 10.1016/j.brainresbull.2007.11.018, 2422999, 18395608.
42. Zhang ZG, Zhang L, Tsang W, Soltanian-Zadeh H, Morris D, Zhang R, Goussev A, Powers C, Yeich T, Chopp M. Correlation of VEGF and angiopoietin expression with disruption of Blood-Brain Barrier and angiogenesis after focal cerebral ischemia. J Cereb Blood Flow Metab 2002, 22:379-92. 10.1097/00004647-200204000-00002, 11919509.
43. Argaw AT, Zhang YT, Snyder BJ, Zhao ML, Kopp N, Lee SC, et al. IL-1 beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program. J Immunol 2006, 177:5574-5584.
44. Knizetova P, Ehrmann J, Hlobilkova A, Vancova I, Kalita O, Kolar Z, et al. Autocrine regulation of glioblastoma cell cycle progression, viability and radioresistance through the VEGF-VEGFR2 (KDR) interplay. Cell Cycle 2008, 7:2553-2561. 10.4161/cc.7.16.6442, 18719373.